PE Anti-HDAC1 + HDAC2 antibody [EPR20327]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal HDAC1 antibody - conjugated to PE.
View Alternative Names
RPD3L1, HDAC1, Histone deacetylase 1, HD1, Protein deacetylase HDAC1, Protein deacylase HDAC1
Related conjugates and formulations (10)
-
Anti-HDAC1 + HDAC2 antibody [EPR20327]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-HDAC1 + HDAC2 antibody [EPR20327]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-HDAC1 + HDAC2 antibody [EPR20327]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-HDAC1 + HDAC2 antibody [EPR20327]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-HDAC1 + HDAC2 antibody [EPR20327]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-HDAC1 + HDAC2 antibody [EPR20327]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-HDAC1 + HDAC2 antibody [EPR20327]
-
HRP Anti-HDAC1 + HDAC2 antibody [EPR20327]
-
Anti-HDAC1+HDAC2 antibody [EPR20327] - BSA and Azide free
-
660 APC
APC Anti-HDAC1 + HDAC2 antibody [EPR20327]
Product details
This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link® conjugation technology, Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Both HDAC1 and HDAC2 are components of large multiprotein complexes such as the Sin3 NuRD and CoREST complexes which are involved in transcriptional regulation. These complexes facilitate the deacetylation of histones transcription factors and other cellular proteins influencing cell cycle progression differentiation and development. HDAC1 and HDAC2 modulate cellular activities impacting cell proliferation and survival.
Pathways
HDAC1 and HDAC2 participate in key cellular processes particularly the cell cycle and apoptosis pathways. These enzymes closely interact with proteins like pRb and E2F influencing the transition between different cell cycle phases. HDAC1 and HDAC2 also connect with tumor suppressor protein p53 affecting apoptotic pathways. By modulating these pathways they play an essential role in maintaining cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com